Netarsudil is a hypotensive drug that reduces intraocular pressure (IOP). Although it is used to treat corneal decompensation/edema in normotensive eyes, we observed the occurrence of corneal epithelial edema with corneal honeycombing in children with uncontrolled IOP (primary or secondary glaucoma) on maximal topical medication following netarsudil (0.02%) therapy of >2 weeks. Of 16 eyes of 16 children, 9 (56%) developed corneal honeycombing. They were younger than those without honeycombing (median age, 3.1 vs 9.7 years [P = 0.016]), had higher baseline IOP (35.6 ± 7.4 vs 27.2 ± 5.6 mm Hg [P < 0.001]), and usually had preexisting corneal edema (7/9 eyes vs none [P < 0.001]).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jaapos.2022.07.005 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Topical Netarsudil in Childhood Glaucoma: A Systematic Review.
Curr Eye Res
January 2025
Department of Ophthalmology, Harvey and Bernice Jones Eye Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Purpose: To evaluate the effectiveness and safety of topical netarsudil 0.02% in managing childhood glaucoma.
Methods: A literature search in the electronic databases of PubMed CENTRAL, Google Scholar, EMBASE, the Register of Controlled Trials, and Ovid MEDLINE from January 2017 to August 2023 using one or a combination of the following terms: "netarsudil," "rhopressa," "Rho-kinase," "pediatric glaucoma," "childhood glaucoma," "intraocular pressure" was conducted.
Ripasudil's paradox: bullous keratopathy with honeycomb twist.
BMJ Case Rep
December 2024
Ophthalmology, All India Institute of Medical Sciences, Nagpur, India.
We present a case of a male patient in his mid-50s who presented with bullous keratopathy secondary to an anterior chamber intraocular lens, complicated by superimposed honeycomb keratopathy while on ripasudil 0.4%. The bullous keratopathy was characterised by generalised microcystic epithelial oedema, alongside more centrally located, variable-sized macrocystic epithelial oedema with a honeycomb appearance.
View Article and Find Full Text PDFA New Ocular Phenotype Combining Juvenile Glaucoma and Doyne Honeycomb Retinal Dystrophy (Malattia Leventinese) due to a Novel EFEMP1 Pathogenic Variant.
Am J Med Genet A
January 2025
Department of Genetics, Institute of Ophthalmology "Conde de Valenciana", Mexico City, Mexico.
Article Synopsis
- Doyne honeycomb retinal dystrophy (DHRD) is a dominantly inherited eye disease that leads to the buildup of material under the retina, affecting vision over time.
- It is primarily caused by a specific genetic mutation in the EFEMP1 gene, with the common variant being p.Arg345Trp.
- This text also discusses a unique case in a family where a different EFEMP1 variant causes both juvenile glaucoma and DHRD, widening our understanding of the genetic causes of these eye conditions.
Reticular Bullous Epithelial Corneal Edema after Netarsudil Use for Elevated Intraocular Pressure with Concurrent Fuchs Endothelial Corneal Dystrophy: A Case Report.
Case Rep Ophthalmol
April 2024
Viterbi Family Department of Ophthalmology, Shiley Eye Institute, University of California San Diego, San Diego, CA, USA.
Introduction: We describe a case of reticular bullous corneal epithelial edema associated with the use of netarsudil ophthalmic solution (0.02%) for elevated intraocular pressure.
Case Presentation: A 74-year-old man with a complex ocular medical history, including Fuchs dystrophy and primary open-angle glaucoma, developed progressively worsening loss of vision 3 weeks following the initiation of topical netarsudil for increased intraocular pressure.
In vivo confocal microscopy findings after Descemet stripping only with and without topical ripasudil supplementation in Fuchs endothelial dystrophy.
Can J Ophthalmol
December 2024
Discipline of Ophthalmology, Sydney Medical School, University of Sydney, Sydney, Australia; Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, BC.
Objective: To report corneal epithelial and corneal endothelial cell (CEC) changes following Descemet stripping only (DSO) with and without topical ripasudil using in vivo confocal microscopy (IVCM).
Methods: Prospective interventional case series of patients who underwent DSO for Fuchs endothelial dystrophy with or without postoperative topical ripasudil (4%, 6 times per day). Patients underwent IVCM (ConfoScan 3; NIDEK Technologies, Padova, Italy) at baseline, monthly until corneal clearance, and then every 6 months.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!